Home › Funds › Revelation Capital Management, LLC › VRDN
Revelation Capital Management, LLC position in VRDN
OBSIDIAN THERAPEUTICS INC · Health Care
Revelation Capital Management, LLC reported holding 428,346 shares of VRDN (OBSIDIAN THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$5.9M, representing 73.40% of its reported portfolio and ranking #1 among its reported holdings. Revelation Capital Management, LLC first reported this position in Q3 2026.
Last updated: 2026-11-03 · Source: SEC EDGAR Form 13F-HR
How Revelation Capital Management, LLC's VRDN position evolved
Revelation Capital Management, LLC first disclosed a stake in VRDN in Q3 2026 at 428,346 shares (US$5.9M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 428.35K | $5.88M | New |
About VRDN and 13F data
VRDN (OBSIDIAN THERAPEUTICS INC) is a Health Care company. 37 other funds we track also report a position in VRDN — the largest reported positions include Bellevue Group AG (US$123.7M), Paradigm Biocapital Advisors LP (US$123.5M), Kynam Capital Management, LP (US$118.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VRDN
- Bellevue Group AG 6.73M sh · $123.67M · Q2 2026
- Paradigm Biocapital Advisors LP 6.72M sh · $123.52M · Q2 2026
- Kynam Capital Management, LP 6.45M sh · $118.56M · Q2 2026
- Fairmount Funds Management LLC 5.09M sh · $93.52M · Q2 2026
- Deep Track Capital, LP 3.59M sh · $66.00M · Q2 2026
- Venrock Adviser, LLC 3.26M sh · $59.85M · Q2 2026
- Avoro Capital Advisors LLC 2.50M sh · $45.92M · Q2 2026
- Context Capital Management, LLC 40.75M sh · $43.82M · Q2 2026
- BAKER BROS. ADVISORS LP 2.38M sh · $43.78M · Q2 2026
- Caligan Partners LP 2.19M sh · $40.30M · Q2 2026
- Novo Holdings A/S 2.13M sh · $39.22M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.79M sh · $32.93M · Q2 2026
More on Revelation Capital Management, LLC
FAQ
How long has Revelation Capital Management, LLC held VRDN?
Revelation Capital Management, LLC has disclosed VRDN holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Revelation Capital Management, LLC's current position in VRDN?
As of Q3 2026, Revelation Capital Management, LLC holds 428.35K shares of VRDN (OBSIDIAN THERAPEUTICS INC), valued at $5.88M, representing 73.40% of its reported portfolio and ranking #1.
Has Revelation Capital Management, LLC been buying or selling VRDN?
In the latest 13F filing (Q3 2026), Revelation Capital Management, LLC newly opened its position in VRDN.
Which other funds hold VRDN?
Other major institutional holders of VRDN include Bellevue Group AG, Paradigm Biocapital Advisors LP, Kynam Capital Management, LP, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.